华威医疗品牌怎么样 申请店铺

我要投票 华威医疗在运动服行业中的票数:626 更新时间:2026-02-13
华威医疗是哪个国家的品牌?「华威医疗」是 杭州华威医疗用品有限公司 旗下著名品牌。该品牌发源于浙江省杭州市,由创始人华 *在1993年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力华威医疗品牌出海!将品牌入驻外推网,定制华威医疗品牌推广信息,可以显著提高华威医疗产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

华威医疗怎么样

杭州华威医疗用品有限公司地处沪、杭、甬“金三角”的交汇点,景色秀丽的富春江畔,占地10万平方米,项目总投资8000万元,是国家食品药品监督管理局定点生产医疗器械的专业厂家。 

公司主要生产经营各种医用缝合针,医用缝合线,手术刀片,医用内窥镜,微创手术器械等系列产品。产品规格齐、品种全,广泛应用于普外科、整形外科、显微外科、五官科、肛肠科、妇科、骨科、泌尿科、胸科、脑科等手术领域。产品畅销全国20多省市并远销全球多个国家和地区,深受海内外客户的赞誉。华威生产经营有20多年的历史,全国拥有近1000家客户。 

二十多年的发展,华威拥有了更坚硬的平台,公司的产品在行业中得到了较高的评价。 拥有多项专利技术和自主知识产权,在国内产品中居优良地位。

公司非常注重科技人才的引进和新产品的开发。目前有各类专业技术人才80余人, 占职工总数的29%, 并聘请同行业专家及各专家院校校高级技术人员定期来指导和培训,解决有关技术问题。为加强技术开发力度,公司开设了市级研发中心,成立了新产品开发小组,负责新产品、新技术的研究、设计、开发、工艺标准和质量标准的制定。并拥有国外引进一系列生产检测设备,使企业更具现代化、规模化。公司的产品在十万级净化车间包装,通过不断完善公司内部管理,各项管理标准严格按照此质量管理体系的要求运行。


Hangzhou Huawei medical supplies Co., Ltd. is located at the intersection of "Golden Triangle" of Shanghai, Hangzhou and Ningbo, along the beautiful Fuchun River, covering an area of 100000 square meters, with a total investment of 80 million yuan. It is a professional manufacturer of medical devices designated by the State Food and drug administration. The company mainly produces and operates a variety of medical suture needle, medical suture, surgical blade, medical endoscope, minimally invasive surgical instruments and other products. The products are of various specifications and varieties, which are widely used in general surgery, plastic surgery, microsurgery, pentalogy, anorectal surgery, gynecology, orthopedics, Urology, chest, brain and other surgical fields. The products sell well in more than 20 provinces and cities and are exported to many countries and regions around the world, and are highly praised by customers at home and abroad. Huawei has a production and operation history of more than 20 years, with nearly 1000 customers nationwide. With more than 20 years of development, Huawei has a harder platform, and its products have been highly appraised in the industry. With a number of patented technologies and independent intellectual property rights, it occupies an excellent position in domestic products. The company attaches great importance to the introduction of scientific and technological talents and the development of new products. At present, there are more than 80 professional and technical talents, accounting for 29% of the total number of employees. Experts from the same industry and senior technical personnel from various expert colleges and universities are invited to guide and train regularly to solve relevant technical problems. In order to strengthen the technical development, the company has set up a municipal R & D center and a new product development team to be responsible for the research, design, development, process standards and quality standards of new products and technologies. And has a series of production and testing equipment imported from abroad, making the enterprise more modern and large-scale. The company's products are packaged in the 100000 level purification workshop. Through continuous improvement of the company's internal management, all management standards are strictly in accordance with the requirements of this quality management system.

本文链接: https://brand.waitui.com/93402bd1e.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

人民币汇率升破6.90,盘中创近三年来新高

2月12日,在岸、离岸人民币对美元汇率双双升破6.90关口,盘中创下2023年4月以来新高。从市场归因来看,结汇盘集中释放是本轮人民币走强的核心驱动力。东方金诚首席宏观分析师王青表示,年末企业结汇需求季节性增加,叠加近期人民币持续升值,此前出口高增所累积的结汇需求有可能加速释放。(上证报)

36分钟前

新基金发行火热,公募备战节后行情

2026开年以来,新基金发行火热。1月新基金发行数量达169只,达到2023年3月以来的最高水平。多只基金一日售罄,还有产品因超募触发比例配售。此外,时隔三年,市场又出现了70亿元级别的主动权益新产品。尽管春节假期临近,但在新基金发行升温的氛围下,机构已开始提前布局春节后的行情,一方面基金公司在节前启动新发,筹备节后推广;另一方面,渠道也在提前布局,抢占节后发行先机。(中证网)

36分钟前

纯债基金发行降至冰点,“固收+”稳居主力地位

2026年以来,债券型基金发行整体遇冷,规模同比显著下滑,其中新发纯债基金只有寥寥数只。与之形成鲜明对比的是,“固收+”基金延续了2025年强势崛起的态势,在新发债基中占据主导地位。业内人士认为,未来居民与机构的配置需求将持续为“固收+”基金发展提供支撑,其在稳健理财领域的地位有望进一步巩固,但与此同时,行业也将面临债市收益承压、产品竞争加剧等多重挑战。(上证报)

36分钟前

调仓换基增配价值品种,基金投顾开年布局求稳

2026开年以来,基金投顾调仓节奏明显加快。统计数据显示,今年1月,近650个基金投顾组合中,有178个进行调仓,增配低估值价值型基金成为共识,永赢融安、华泰柏瑞红利低波ETF联接等产品获基金投顾增配比例最高。在大类资产配置层面,基金投顾组合普遍提升了A股及债券仓位,同步减配现金资产、美股及港股持仓;行业维度则增配有色金属、电子、通信,减配生物医药、汽车及银行。(中证网)

36分钟前

爱彼迎第四季度营收为28亿美元,同比增长12%

当地时间2月12日,爱彼迎公布第四季度及全年业绩报告。报告显示,第四季度爱彼迎营收为28亿美元,同比增长12%;第四季度净利润为3.41亿美元,净利润率为12%;第四季度预订总额为204亿美元,同比增长16%。2025年全年爱彼迎营收为122亿美元,同比增长10%;第四季度净利润为25亿美元,净利润率为21%;第四季度预订总额为913亿美元,同比增长12%。(界面)

36分钟前

本页详细列出关于华威医疗的品牌信息,含品牌所属公司介绍,华威医疗所处行业的品牌地位及优势。
咨询